BILAG-2004
Showing 1 - 25 of 675
Lupus Erythematosus, Systemic Trial in Beijing (low dose GR1603 in phase ?b, high dose GR1603 in phase?b, low dose GR1603 in
Recruiting
- Lupus Erythematosus, Systemic
- low dose GR1603 in phase Ⅰb
- +4 more
-
Beijing, Beijing, ChinaPeking union Medical Hosipital
Aug 22, 2023
Systemic Lupus Erythematosus Trial (Placebo, Ianalumab)
Not yet recruiting
- Systemic Lupus Erythematosus
- Placebo
- Ianalumab
- (no location specified)
Nov 15, 2023
Systemic Lupus Erythematosus Trial (Anifrolumab, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Anifrolumab
- Placebo
- (no location specified)
Apr 18, 2023
Active Systemic Lupus Erythematosus Trial in Worldwide (Anifrolumab, )
Recruiting
- Active Systemic Lupus Erythematosus
- Anifrolumab
- placebo
-
Baoding, China
- +71 more
Jan 13, 2023
Systemic Lupus Erythematosus Trial (Ianalumab, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Ianalumab
- Placebo
- (no location specified)
Dec 5, 2022
Systemic Lupus Erythematosus Trial (ianalumab, )
Not yet recruiting
- Systemic Lupus Erythematosus
- ianalumab
- placebo
- (no location specified)
Nov 21, 2022
Systemic Lupus Erythematosus Trial in Shanghai (Relma-cel)
Recruiting
- Systemic Lupus Erythematosus
- Relma-cel
-
Shanghai, ChinaRelma-cel Medical
Mar 12, 2023
Systemic Lupus Erythematosus Trial in Worldwide (Dapirolizumab pegol)
Enrolling by invitation
- Systemic Lupus Erythematosus
- Dapirolizumab pegol
-
Tucson, Arizona
- +36 more
Aug 11, 2022
Lupus Erythematosus, Systemic Trial in Worldwide (BIIB059, BIIB059 matching )
Recruiting
- Lupus Erythematosus, Systemic
- BIIB059
- BIIB059 matching placebo
-
Upland, California
- +41 more
Apr 19, 2022
Systemic Lupus Erythematosus, SLE, Lupus Trial in United States (JBT-101, Placebo)
Completed
- Systemic Lupus Erythematosus
- +2 more
- JBT-101
- Placebo
-
La Jolla, California
- +15 more
Oct 27, 2022
Systemic Lupus Erythematosus, SLE Trial in China (Orelabrutinib (Low Dose), Orelabrutinib (High Dose), Orelabrutinib Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus, SLE
- Orelabrutinib (Low Dose)
- +2 more
-
Bengbu, Anhui, China
- +38 more
Jan 18, 2023
Systemic Lupus Erythematosus (SLE) Trial (BRL-301)
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- BRL-301
- (no location specified)
Aug 13, 2023
Systemic Lupus Erythematosus Trial in Worldwide (Obinutuzumab, Placebo, Acetaminophen/Paracetamol)
Recruiting
- Systemic Lupus Erythematosus
- Obinutuzumab
- +4 more
-
Birmingham, Alabama
- +72 more
Aug 17, 2022
Active Systemic Lupus Erythematosus Trial in Worldwide (Efavaleukin Alfa, Placebo, Standard of Care)
Recruiting
- Active Systemic Lupus Erythematosus
- Efavaleukin Alfa
- +2 more
-
Birmingham, Alabama
- +148 more
Jan 18, 2023
Systemic Lupus Erythematosus, Lupus Nephritis Trial in Barcelona (YTB323)
Recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
-
Barcelona, Catalunya, SpainNovartis Investigative Site
Mar 22, 2023
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (VAY736, VAY736 Placebo, CFZ533)
Active, not recruiting
- Systemic Lupus Erythematosus (SLE)
- VAY736
- +3 more
-
Ciudad Autonoma de Bs As, Buenos Aires, Argentina
- +31 more
Sep 19, 2022
Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Diffuse Scleroderma Trial in Shanghai (BRL-301)
Recruiting
- Systemic Lupus Erythematosus (SLE)
- +5 more
- BRL-301
-
Shanghai, Shanghai, ChinaShanghai ChangZheng hospital
May 7, 2023
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Rozibafusp Alfa, Placebo for Rozibafusp Alfa)
Recruiting
- Systemic Lupus Erythematosus (SLE)
- Rozibafusp Alfa
- Placebo for Rozibafusp Alfa
-
Birmingham, Alabama
- +146 more
Feb 1, 2023
Systemic Lupus Erythematosus Trial in New York, Oklahoma City (Herpes Zoster Subunit (HZ/su) Vaccine, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Herpes Zoster Subunit (HZ/su) Vaccine
- Placebo
-
New York, New York
- +1 more
Jan 6, 2023
Systemic Lupus Erythematosus Trial in Worldwide (Lupuzor)
Terminated
- Systemic Lupus Erythematosus
-
Birmingham, Alabama
- +84 more
Dec 5, 2022
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (BIIB059, BIIB059-matching )
Recruiting
- Systemic Lupus Erythematosus (SLE)
- BIIB059
- BIIB059-matching placebo
-
Mesa, Arizona
- +280 more
Jul 20, 2022
Systemic Lupus Erythematosus (SLE) Trial in China (SG301 SC Injection)
Recruiting
- Systemic Lupus Erythematosus (SLE)
- SG301 SC Injection
-
Bengbu, Anhui, China
- +9 more
Nov 17, 2023
Systemic Lupus Erythematosus Trial in Bordeaux (blood sample)
Not yet recruiting
- Systemic Lupus Erythematosus
- blood sample
-
Bordeaux, FranceCHU de Bordeaux - Médecine Interne et Immunologie Clinique
Jan 13, 2023